$82.3 Million is the total value of JGP Global Gestao de Recursos Ltda.'s 55 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KHC | New | KRAFT HEINZ CO/THEput | $23,672,000 | – | 550,000 | +100.0% | 28.75% | – |
| EWZ | New | ISHARES MSCI BRAZIL ETFetp | $19,100,000 | – | 500,000 | +100.0% | 23.20% | – |
| GE | New | GENERAL ELECTRIC CO | $12,112,000 | – | 1,600,000 | +100.0% | 14.71% | – |
| EEM | New | ISHARES MSCI EMERGING MARKETcall | $1,953,000 | – | 50,000 | +100.0% | 2.37% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $1,468,000 | – | 5,893 | +100.0% | 1.78% | – |
| XOP | New | SPDR S&P OIL & GAS EXP & PRcall | $1,327,000 | – | 50,000 | +100.0% | 1.61% | – |
| ILMN | New | ILLUMINA INC | $875,000 | – | 2,917 | +100.0% | 1.06% | – |
| PAGS | New | PAGSEGURO DIGITAL LTD-CL A | $805,000 | – | 43,000 | +100.0% | 0.98% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $782,000 | – | 7,166 | +100.0% | 0.95% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $628,000 | – | 6,449 | +100.0% | 0.76% | – |
| HUM | New | HUMANA INC | $586,000 | – | 2,044 | +100.0% | 0.71% | – |
| CI | New | CIGNA CORP | $541,000 | – | 2,850 | +100.0% | 0.66% | – |
| BGNE | New | BEIGENE LTD-ADRadr | $527,000 | – | 3,757 | +100.0% | 0.64% | – |
| CNC | New | CENTENE CORP | $480,000 | – | 4,160 | +100.0% | 0.58% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $477,000 | – | 4,983 | +100.0% | 0.58% | – |
| ABT | New | ABBOTT LABORATORIES | $418,000 | – | 5,781 | +100.0% | 0.51% | – |
| DXCM | New | DEXCOM INC | $411,000 | – | 3,433 | +100.0% | 0.50% | – |
| EWZ | New | ISHARES MSCI BRAZIL ETFput | $382,000 | – | 10,000 | +100.0% | 0.46% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $372,000 | – | 2,245 | +100.0% | 0.45% | – |
| EXAS | New | EXACT SCIENCES CORP | $370,000 | – | 5,863 | +100.0% | 0.45% | – |
| MRK | New | MERCK & CO. INC. | $360,000 | – | 4,716 | +100.0% | 0.44% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $338,000 | – | 2,208 | +100.0% | 0.41% | – |
| AGN | New | ALLERGAN PLC | $330,000 | – | 2,466 | +100.0% | 0.40% | – |
| BLUE | New | BLUEBIRD BIO INC | $325,000 | – | 3,281 | +100.0% | 0.40% | – |
| ABBV | New | ABBVIE INC | $318,000 | – | 3,454 | +100.0% | 0.39% | – |
| ANTM | New | ANTHEM INC | $309,000 | – | 1,177 | +100.0% | 0.38% | – |
| LLY | New | ELI LILLY & CO | $304,000 | – | 2,631 | +100.0% | 0.37% | – |
| CELG | New | CELGENE CORP | $292,000 | – | 4,551 | +100.0% | 0.36% | – |
| GHDX | New | GENOMIC HEALTH INC | $286,000 | – | 4,438 | +100.0% | 0.35% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $279,000 | – | 7,723 | +100.0% | 0.34% | – |
| BIIB | New | BIOGEN INC | $257,000 | – | 855 | +100.0% | 0.31% | – |
| GWPH | New | GW PHARMACEUTICALS -ADRadr | $242,000 | – | 2,480 | +100.0% | 0.29% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $237,000 | – | 5,764 | +100.0% | 0.29% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $214,000 | – | 2,997 | +100.0% | 0.26% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $205,000 | – | 548 | +100.0% | 0.25% | – |
| ARGX | New | ARGENX SE - ADRadr | $202,000 | – | 2,100 | +100.0% | 0.24% | – |
| AMRN | New | AMARIN CORP PLC -ADRadr | $150,000 | – | 11,024 | +100.0% | 0.18% | – |
| EPZM | New | EPIZYME INC | $76,000 | – | 12,398 | +100.0% | 0.09% | – |
| PTI | New | PROTEOSTASIS THERAPEUTICS IN | $64,000 | – | 19,790 | +100.0% | 0.08% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $50,000 | – | 12,568 | +100.0% | 0.06% | – |
| OIBRQ | New | OI SA-ADRadr | $7,000 | – | 28,567 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-01-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BMRN | 33 | Q2 2024 | 2.8% |
| INCYTE CORP | 31 | Q2 2024 | 3.9% |
| LILLY ELI & CO | 29 | Q2 2024 | 2.5% |
| VERTEX PHARMACEUTICALS INC | 29 | Q2 2024 | 3.9% |
| REGENERON PHARMACEUTICALS | 29 | Q2 2024 | 1.6% |
| UNITEDHEALTH GROUP INC | 27 | Q2 2024 | 5.9% |
| ACADIA PHARMACEUTICALS INC | 27 | Q2 2024 | 0.8% |
| THERMO FISHER SCIENTIFIC INC | 24 | Q2 2024 | 4.7% |
| BEIGENE LTD-ADR | 23 | Q2 2024 | 5.5% |
| ELEVANCE HEALTH INC | 23 | Q2 2024 | 1.5% |
View JGP Global Gestao de Recursos Ltda.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-02 |
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-01-19 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-04 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-05 |
View JGP Global Gestao de Recursos Ltda.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.